Martin K. Church, Marysia Tiongco-Rectob, Erminia Ridoloc and Zoltan Novàk.
Bilastine is a potent and highly selective H1-antihistamine approved for the treatment of allergic rhinoconjunctivitis and urticaria. This article summarizes available data on the use of bilastine in the treatment of allergic disorders in different age groups, including younger and older adults, and school-age children and adolescents.
